Global Radiosurgery and Radiotherapy Robotics Market - Drivers and Forecast From Technavio

Technavio has announced the release of their 'Global Radiosurgery and Radiotherapy Robotics Market 2017-2021' report. (Graphic: Business Wire)

???pagination.previous??? ???

LONDON--()--Technavio analysts forecast the global radiosurgery and radiotherapy robotics market to grow to USD 6.09 billion by 2021, at a CAGR of more than 6% over the forecast period, according to their latest report.

The research study by Technavio on the global radiosurgery and radiotherapy robotics market for 2017-2021 provides detailed industry analysis based on radiation beam used (X-ray and gamma ray) and geography (the Americas, EMEA, and APAC).

Radiosurgery is usually an oncologic treatment, which involves removing tumor cells through ionized radiation beams. Radiotherapy, which is similar to radiosurgery, uses multiple fractionated doses of radiation to treat the tumor, thus requiring multiple sittings. These two therapies are expected to emerge as major methods of treatment for cancerous and non-cancerous tumors during the forecast period.

Looking for more research from this report? Request a sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

Technavio analysts highlight the following three factors that are contributing to the growth of the global radiosurgery and radiotherapy robotics market:

  • Rise in product innovations
  • Increase in cancer cases and retreatments
  • Developments in reimbursements procedures

Rise in product innovations

The technological advances in non-invasive surgeries have led to the introduction of new innovative products with enhanced durability. The development of precise and accurate imaging instruments for determining the size, location, and shape of the tumor will add a boost to the market growth,” says Bharath Kanniappan, a lead analyst at Technavio for robotics research.

The increasing emphasis towards high-definition (HD) systems capable of offering high-resolution images is creating a favorable environment for vendors with advanced product offerings. Also, vendors are ensuring that radiosurgery and radiotherapy robots are capable of integrating functions such as imaging, treatment planning, dose verification, quality assurance, and post-treatment analysis capabilities.

Increase in cancer cases and retreatments

A rising number of physicians and hospitals in the oncology field are adopting radiosurgery and radiotherapy robots for the treatment of lesions and tumors. These treatments provide a shorter treatment time and greater patient throughput, which ensures that the patient resumes regular daily life very soon. Also, since radiosurgery allows a very precise dose distribution, it limits the exposure of healthy tissues to excessive radiation. Similarly, this treatment option allows for enhanced treatment of spine tumors, which are usually very hard to treat. Such varied applications are leading to the growth of the global radiosurgery and radiotherapy robotics market.

Developments in reimbursements procedures

“The reimbursement scenario for radiosurgery and radiotherapy treatments vary significantly, depending on the government in the region. However, the improving scenario is encouraging more patients to opt for these therapies, resulting in greater revenue generation in the market,” says Bharath.

The US and the UK have some of the most supportive reimbursement scenarios. In the US, private insurance plans provide coverage under an indemnity plan and cover a fixed percentage of medical costs. Meanwhile, the UK has a socialized healthcare system known as the National Health Service (NHS), which covers non-invasive procedures. Germany, Spain, Italy, and France are other countries with supportive reimbursement policies.

Browse Related Reports:

Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like automation. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently.

About Technavio

Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, resellers, and end-users.

If you are interested in more information, please contact our media team at


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770

Release Summary

Technavio has announced the release of their Global Radiosurgery and Radiotherapy Robotics Market 2017-2021 report.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770